Navigation Links
Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal
Date:5/19/2009

                 - Company to Also Present Clinical Data at
                        Upcoming Scientific Meeting -

LAVAL, QC, May 19 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the publication of Extended Release Trazodone in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study in the May 2009 issue of the journal Psychiatry (Edgemont) (Volume 6, Number 5) (www.psychiatrymmc.com). The results of this Phase III clinical trial (study 04ACL3-001), which were originally reported by the Company in February 2008, demonstrate clear benefits for Labopharm's novel antidepressant.

More than 120 million people around the world suffer from depression. Treatment is often challenging because response to antidepressant drug therapy can vary significantly. Clinically depressed patients are typically treated with two different types of drug therapy: selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs)). However, some 40 to 50% of patients being treated for depression stop taking these antidepressant drugs within the first 12 months of treatment. Frequently cited reasons for discontinuing therapy include suboptimal efficacy on depression symptoms, exacerbation of sleep disturbance, increased agitation, slow onset of action, sexual dysfunction and weight gain.

Labopharm's novel formulation of the antidepressant trazodone is designed to optimize the efficacy of trazodone, and address the major challenges in treating depression.

Summary of Results of Labopharm's Phase III Clinical Trial on Trazodone

Labopharm's multi-center phase III clinical trial compared the efficacy and safety of Labopharm's novel trazodone formulation to placebo in patien
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. International Isotopes Inc. Announces First Quarter 2009 Financial Results
2. Encision Reports Fourth Quarter and Fiscal Year 2009 Results
3. Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009
4. BMP Sunstone Reports First Quarter 2009 Financial Results
5. Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
6. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
7. Jiangbo Pharmaceuticals Reports Results for the Third Quarter of its Fiscal Year 2009
8. AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results
9. Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
10. Derma Sciences Reports First Quarter 2009 Results
11. NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... (PRWEB) May 24, 2015 The ... ( http://www.testosteronelawsuithub.com/ ) has scheduled its next monthly ... the multidistrict litigation. According to court documents filed ... Illinois, the Conference will be convened on June ... Replacement Therapy Product Liability Litigation - MDL No. ...
(Date:5/24/2015)... A report out just last ... best option for avoiding cardiovascular disease is exercise and ... the single most powerful predictor of death and survival, ... and family history of premature death -- a finding ... lung fitness. , The Importance of Cardiovascular Screening , ...
(Date:5/23/2015)... 2015 On Wednesday, May 20, 2015, ... has been the target of a sophisticated cyberattack,” and ... company’s ongoing Information Technology (IT) security efforts in the ... The most notable attack on health insurers was reported ... nation’s second largest health insurer, revealed that they had ...
(Date:5/23/2015)... May 23, 2015 Add High-Quality prismatic refractions ... Film Studios. , It's as simple as dragging and dropping ... included tool for full effect. , Including over 80 ... range 5k sensors making this the ultimate bundle for adding ... included in this package are movie files designed for Final ...
(Date:5/22/2015)... May 22, 2015 Mountain Point Medical Center, ... ribbon cutting ceremony on Friday, May 29, 2015 at 11 ... 6 p.m. The new medical center, set to officially open ... Boulevard, Lehi, UT 84043. , “The opening of Mountain ... and the Utah County community,” said Kent Loosle, CEO of ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2
... has discovered genetic variants that control arsenic metabolism and ... exposed to arsenic. In PLoS Genetics , researchers ... Center for Diarrheal Disease Research in Bangladesh, and the ... near the enzyme for metabolizing the chemical into a ...
... , THURSDAY, Feb. 23 (HealthDay News) -- ... how well you sleep, researchers report. Southerners report ... in the West have the least, according to a ... United States. University of Pennsylvania researchers created the ...
... -- A home-visit program for children with asthma reduced ... saved $1.46 for every dollar spent, according to a ... Community Asthma Initiative, a community-based asthma care program for ... team at Children,s Hospital Boston. The program includes ...
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Feb. 22 ... of the body is almost always fatal, but a new ... type of this skin cancer, researchers report. A mutation ... who develop melanoma. Researchers say Zelboraf (vemurafenib), a drug approved ...
... 23 (HealthDay News) -- A second company reports that it ... potentially providing yet another option for pregnant women who want ... Last fall, Sequenom Inc. announced that it was making a ... the United States. It marked the first time that pregnant ...
... study published in the American Journal of Transplantation ... in graft rejection that would have been prevented by certain ... the University of Texas Health Science Center, researchers used mouse ... (SHS) on transplant survival and its mechanism of action. ...
Cached Medicine News:Health News:Genetic variants affect arsenic metabolism and toxicity in Bangladesh 2Health News:Southerners Sleepiest, U.S. 'Sleep Map' Shows 2Health News:Home-Visit Program May Improve Child's Asthma 2Health News:New Melanoma Drug May Extend Survival 2Health News:New Melanoma Drug May Extend Survival 3Health News:Blood Test Detects Down Syndrome During Pregnancy 2
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... DETROIT, Dec. 7, 2010 As previously disclosed, Sun Pharmaceutical ... which own 75.8% of Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... a "going private" transaction by which Sun Pharma would acquire ... held by Sun Pharma for a per share consideration of ...
... Va., Dec. 7, 2010 Oxford Finance ... to announce the addition of Debbie Baker to its ... responsible for originating loan facilities for life science and ... Ms. Baker has over 30 years of financial ...
Cached Medicine Technology:Independent Committee of Caraco Board to Consider Sun Pharma Proposal to Purchase Outstanding Shares 2Independent Committee of Caraco Board to Consider Sun Pharma Proposal to Purchase Outstanding Shares 3Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America 2
... has redefined rimless collections forever.,The Airlock mounting ... end of each frame mounting. This precisely ... that mounts within the lens. When the ... is created that far exceeds that of ...
55 DSL's new collection of optical frames has established a strong personality and developed,superficial retro concepts with contemporary styles and strong impacting colours....
The Alexander McQueen eyewear collection focuses on a distinctive sophisticated style, with feminine lines, assertive shapes and original silhouettes....
... developed by doctors, tests for elevated thyroid ... TSH is the first clinical indicator of ... is easy to use, cost effective and accurate. ... labs, pharmacy programs and health promotion. , ThyroChek ...
Medicine Products: